Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples